Recursion Pharmaceuticals (RXRX), Crispr Therapeutics (CRSP), iShares MSCI India (INDA), Faraday Future Intelligent Electric (FFIE), Bilibili (BILI), Procter & Gamble (PG), UP Fintech Holding Ltd ...
Investors know the biotech industry is a waiting game—smaller companies in this space often work to secure the funding to ...
In the most recent trading session, Recursion Pharmaceuticals (RXRX) closed at $8.50, indicating a +1.92% shift from the previous trading day.
Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.
Recursion Pharmaceuticals (RXRX) was a big mover last session on higher-than-average trading volume. The latest trend in ...
Recursion Pharmaceuticals (RXRX) closed at $7.66 in the latest trading session, marking a +0.13% move from the prior day.
Recursion Pharmaceuticals (RXRX) is a clinical-stage biotechnology company utilizing artificial intelligence to expedite drug ...
The chip maker got a shout out from Amazon CEO Andy Jassy on a fourth-quarter earnings call with analysts. Trump's tariffs on Canada and Mexico are delayed. Economic turmoil is here. Big Tech is a ...
SG Americas Securities LLC lowered its position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 44.8% during the fourth quarter, HoldingsChannel reports. The firm owned 49,343 shares ...